A carregar...

HOW BEST TO USE NEW THERAPIES IN MULTIPLE MYELOMA

Advances in the molecular understanding of myeloma have led to the development of novel agents such as immunomodulatory drugs (IMiDs) and proteasome inhibitors (bortezomib). When used alone, these agents have significant activity against myeloma and responses increase significantly when they are com...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dingli, David, Rajkumar, S. Vincent
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2867034/
https://ncbi.nlm.nih.gov/pubmed/20359801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.blre.2010.03.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!